USP monographs
This article was originally published in The Tan Sheet
Executive Summary
Eleven proposed monographs for dietary supplements have been released for public comment, the U.S. Pharmacopeia states Nov. 15. Six turmeric-related monographs, three soy isoflavones monographs and two monographs for single ingredient amino acid formulations contain specific and validated analytical methods that will ensure the identify of the articles and protect consumers and industry from low-quality and adulterated products, USP says. Separately, USP announces Nov. 12 that it has completed a review of IVC Industries' B-50 Tablets and concluded the product does contain the amount of folic acid stated on its label and does meet USP dissolution requirements. USP conducted its assessment after ConsumerLab.com identified B-50 tablets as one of 10 multivitamins that do not contain label amounts of folic acid. B-50 Tablets are part of USP's Dietary Supplement Verification Program and carries the USP Verified mark...
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.